Alrex® Versus Patanol in the Treatment of Seasonal Allergic Conjunctivitis(SAC)

Update Il y a 4 ans
Reference: NCT01435460

Woman and Man

  • | Country :
  • Singapore
  • | organs :
  • -
  • | Specialty :
  • -

Extract

This study is to evaluate the safety and efficacy of Alrex (LE ophthalmic suspension, 0.2%) versus Patanol (olopatadine hydrochloride ophthalmic solution, 0.1%) in the temporary relief of the signs and symptoms of Seasonal Allergic Conjunctivitis (SAC).


Inclusion criteria

  • Seasonal Allergic Conjunctivitis

Links